Kyo C. Lee

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

NMB Innovators Series Professor Dae Yoon Chi, Ph.D.: Understanding of 18F-chemistry and its applications toward drug developments used in diagnosis and therapeutics.

NMB Innovators Series Professor Dae Yoon Chi, Ph.D.: Understanding of 18F-chemistry and its applications toward drug developments used in diagnosis and therapeutics.

Journal: Nuclear medicine and biology

Published: April 03, 2026

Current Status of PSMA-Targeted Agents Based on Small Molecules for Prostate Cancer in Preclinical Studies.

Current Status of PSMA-Targeted Agents Based on Small Molecules for Prostate Cancer in Preclinical Studies.

Journal: Nuclear medicine and molecular imaging

Published: September 04, 2025

Preclinical evaluation and dosimetry of [64Cu/67Cu]Cu-NGUL for PSMA-targeted prostate cancer theranostics.

Preclinical evaluation and dosimetry of [64Cu/67Cu]Cu-NGUL for PSMA-targeted prostate cancer theranostics.

Journal: Nuclear medicine and biology

Published: September 03, 2025

2D van der Waals System Integrated with Targeting Radio-Diagnostic and Imaging Functions.

2D van der Waals System Integrated with Targeting Radio-Diagnostic and Imaging Functions.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: May 13, 2025

Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls.

Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls.

Journal: Experimental neurobiology

Published: February 20, 2025

Comparative Study of Dimeric Fibroblast Activation Protein-Targeting Radioligands Labeled with Fluorine-18, Copper-64, and Gallium-68.

Comparative Study of Dimeric Fibroblast Activation Protein-Targeting Radioligands Labeled with Fluorine-18, Copper-64, and Gallium-68.

Journal: Molecular pharmaceutics

Published: December 30, 2024

Evaluation of Dynamic Light Scattering as an Effective Quality Control Method for Aggregates in Radiolabeled Antibodies.

Evaluation of Dynamic Light Scattering as an Effective Quality Control Method for Aggregates in Radiolabeled Antibodies.

Journal: Journal of medicinal chemistry

Published: December 16, 2024

Evaluating 64 Cu-DOTA-rituximab as a PET agent in patients with B-cell lymphoma: a head-to-head comparison with 18 F-fluorodeoxyglucose PET/computed tomography.

Evaluating 64 Cu-DOTA-rituximab as a PET agent in patients with B-cell lymphoma: a head-to-head comparison with 18 F-fluorodeoxyglucose PET/computed tomography.

Journal: Nuclear medicine communications

Published: August 19, 2024

Feasibility Study of Single-Photon Emission Computed Tomography with Iodine-123 Labeled Metaiodobenzylguanidine for Preclinical Evaluation of Labetalol as a β-Adrenergic Receptor Blocker.

Feasibility Study of Single-Photon Emission Computed Tomography with Iodine-123 Labeled Metaiodobenzylguanidine for Preclinical Evaluation of Labetalol as a β-Adrenergic Receptor Blocker.

Journal: Molecular pharmaceutics

Published: April 16, 2024

Efficient Radiolabeling of Proteins and Antibodies via Maleamate-Cysteine Bioconjugation.

Efficient Radiolabeling of Proteins and Antibodies via Maleamate-Cysteine Bioconjugation.

Journal: ACS medicinal chemistry letters

Published: February 27, 2024

From molecules to medicine: thiol selective bioconjugation in synthesis of diagnostic and therapeutic radiopharmaceuticals.

From molecules to medicine: thiol selective bioconjugation in synthesis of diagnostic and therapeutic radiopharmaceuticals.

Journal: Theranostics

Published: February 19, 2024

64Cu-Labeled Boron-Containing Cyclic RGD Peptides for BNCT and PET Imaging.

64Cu-Labeled Boron-Containing Cyclic RGD Peptides for BNCT and PET Imaging.

Journal: ACS medicinal chemistry letters

Published: January 05, 2024

Showing 1-12 of 87

Last Updated: 09/26/2026